𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Pharmacokinetics of quinine in chronic liver disease.

✍ Scribed by P. Auprayoon; K. Sukontason; K. Na-Bangchang; V. Banmairuroi; P. Molunto ; J. Karbwang

Book ID
119833585
Publisher
John Wiley and Sons
Year
1995
Tongue
English
Weight
727 KB
Volume
40
Category
Article
ISSN
0306-5251

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Pharmacokinetics of isradipine in patien
Pharmacokinetics of isradipine in patients with chronic liver disease
✍ J. Cotting; J. Reichen; K. Kutz; R. Laplanche; E. NΓΌesch πŸ“‚ Article πŸ“… 1990 πŸ› Springer 🌐 English βš– 523 KB

The pharmacokinetics of the dihydropyridine calcium antagonist isradipine has been examined in 8 healthy volunteers, 7 patients with non-cirrhotic chronic liver disease (CLD), and 8 patients with biopsy-proven cirrhosis (CIR). Isradipine was simultaneously given orally (12C 5 mg) and i.v. (13C 1 mg)

Pharmacokinetics of quinine in patients
Pharmacokinetics of quinine in patients with chronic renal failure
✍ P. Rimchala; J. Karbwang; K. Sukontason; V. Banmairuroi; P. Molunto; K. Na-Bangc πŸ“‚ Article πŸ“… 1996 πŸ› Springer 🌐 English βš– 521 KB

Methods: We investigated the pharmacokinetics of quinine (Qn) following administration of a single oral dose of 600 mg Qn sulphate in six male Thai patients with a moderate degree of chronic renal failure (CRF), and six male Thai subjects with normal renal function. ## Results: The drug was well